lawmakers ought to keep their promises when it comes to tax cuts before rushing ahead with a second bill.

That promise to the middle-class worker that, on average, they were going to get a $4,000 pay raise, has not been kept.

We have gotten it done and our job now is to build on that accomplishment.

Senator Wyden sent Senator Hatch a letter describing 17 provisions in the legislative text that...did not reflect the decisions made by committee members.

supporters of the tax legislation will often justify the bill in terms of a rise in economic growth, but that effect is very small, could be better achieved in other superior ways.

Once again, the fortunate few are reaping the benefits.

nearly half of the benefit of the new pass-through rate is going to taxpayers with incomes of $1 million or more.

The reality is the new law has done little for folks who work so hard to earn a wage and cover the bills.

the new tax law has turned out to be an awfully expensive dud.

Colleagues, in my view, lawmakers ought to think twice about big, new promises if they have not delivered on the ones they have already made.

It's estimated that 83 percent of the benefits of the tax cuts will go to the top 1 percent.

in those small communities on Main Street in eastern Oregon, when you think Main Street, you do not think of millionaires.

Americans Abroad were an unintended target of these new laws.

Congress would be derelict in its responsibilities if it pretends there is no profit motive or corporate scheming behind this addiction crisis.

I would like to associate myself with the remarks, the bipartisan remarks and approach we have to this problem, stated by my colleague and friend from Oregon, who did start out in Kansas.

I appreciate your attention to this important issue and your consideration of my requests.

I think that the opioid manufacturers, through twisted research, deceptive marketing, and bought-and-paid-for advocacy groups, had a significant role to play in creating and fueling the crisis.

It is long past time to get the opioid executives before this committee, have them raise their right hands, and hold them accountable for their role in creating a public health calamity that is killing tens of thousands of Americans each…

We are going to get a bipartisan bill from the Finance Committee, because Chairman Hatch and I have been talking about this for some time.

To me, opioid manufacturers--through twisted research, deceptive marketing, and bought and paid-for patient advocacy groups--had a significant role in fueling the crisis.

We are going to do that under the leadership of the chairman. This is going to be tackled in the same kind of way that we pursued the CHIP bill for 10 years, the historic Family First bill, the potentially transformative Medicare…

Thank you, Senator Casey.

In 2017, I wrote again to HHS regarding a workshop hosted by the Food and Drug Administration on safe opioid prescribing when it was revealed that some participants shared financial ties with Purdue Pharma and other prominent manufacturers.

We have a public health calamity on our hands, thousands of deaths.

When we wrap up, we are going to ask that there be a response to questions for the record...